Characteristics, treatment and lung function outcomes of pulmonary exacerbations in cystic fibrosis: insights from the BEAT-CF cohort

医学 肺功能 队列 肺 重症监护医学 队列研究 内科学 平衡(能力) 肺功能测试 肺病 功能损害 儿科 呼吸道疾病 肺容积 梅德林 回顾性队列研究
作者
Parveen Fathima,Edward Pan,Julie Marsh,Shivanthan Shanthikumar,Sheila Sivam,Adam Jaffé,Hiran Selvadurai,Ameneh Khatami,Geshani Jayasuriya,Richard Norman,Andrew Tai,Lucy Burr,Siobhain Mulrennan,Tom Snelling,André Schultz
出处
期刊:The European respiratory journal [European Respiratory Society]
卷期号:67 (1): 2501349-2501349 被引量:3
标识
DOI:10.1183/13993003.01349-2025
摘要

Background Pulmonary exacerbations pose a significant clinical burden on people with cystic fibrosis (pwCF). Whether management of exacerbations should change in the context of modulator therapy is unclear. We describe the characteristics, treatment and lung function outcomes of pulmonary exacerbations requiring intravenous antibiotic therapy (PERITs) in a contemporary Australian cohort of pwCF, in an era of rapidly broadening access to modulator therapy. Methods PwCF receiving care at 11 Australian specialist centres were prospectively enrolled between 14 October 2020 and 9 October 2024. Spirometry data and treatments received during a PERIT were collected systematically. Results A total of 982 pwCF were enrolled, with 593 PERITs recorded in 323 individuals. The median (interquartile range) age at PERIT start was 12 (7–17) years and the mean± sd baseline forced expiratory volume in 1 s (FEV 1 ) % predicted across PERITs was 80±21%. Approximately 62% (n=366) of PERITs occurred in people receiving modulator therapy. Intravenous tobramycin (63%) and piperacillin-tazobactam (43%) were the most frequently used antibiotics. Among participants with spirometry at baseline and at Day 7 (n=296) or Day 60 (n=383), 41% (n=120) and 44% (n=169) were below their baseline at Day 7 and Day 60 after commencing treatment, respectively; 8% were >10% below their baseline FEV 1 % predicted at both time-points. Recovery patterns were consistent regardless of baseline lung function, Pseudomonas aeruginosa colonisation or modulator use. Conclusion The pattern and magnitude of lung function impairment during PERITs is similar among those receiving and not receiving modulator therapy. This underscores the continued need for evidence to help clinicians balance treatment burden against the risk of irreversible loss of lung function.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
我是谁的应助被科研通管家采纳,获得50
1秒前
CodeCraft的应助被科研通管家采纳,获得10
1秒前
863发布了新的文献求助10
1秒前
入司的应助被LJH采纳,获得10
1秒前
Tom发布了新的文献求助10
1秒前
xdlongchem发布了新的文献求助10
1秒前
1秒前
TCMning发布了新的文献求助10
1秒前
崔世强发布了新的文献求助10
1秒前
xuexi发布了新的文献求助10
3秒前
4秒前
wwj完成签到,获得积分20
6秒前
7秒前
7秒前
zzz完成签到,获得积分10
7秒前
完美世界的应助被xing采纳,获得10
7秒前
爆米花的应助被TCMning采纳,获得10
7秒前
不能喝完成签到,获得积分20
8秒前
8秒前
xdlongchem完成签到,获得积分10
8秒前
10秒前
黑猩123完成签到,获得积分10
10秒前
Prospect发布了新的文献求助10
11秒前
11秒前
传奇3的应助被忧郁雁卉采纳,获得10
12秒前
青衫发布了新的文献求助10
12秒前
wzllyt完成签到,获得积分10
13秒前
interguy发布了新的文献求助10
13秒前
来了完成签到,获得积分10
13秒前
13秒前
14秒前
雾散完成签到 ,获得积分10
14秒前
微明完成签到,获得积分10
15秒前
lqiu完成签到,获得积分10
15秒前
科研通AI6.4的应助被ffy采纳,获得10
16秒前
16秒前
wjw发布了新的文献求助10
17秒前
lin的应助被liuliu采纳,获得10
17秒前
lin的应助被liuliu采纳,获得10
17秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188885
求助须知:如何正确求助?哪些是违规求助? 9576493
关于积分的说明 21847858
捐赠科研通 7786920
什么是DOI,文献DOI怎么找? 3435460
关于科研通互助平台的介绍 2559669
邀请新用户注册赠送积分活动 2482383